ANTIDEPRESSANT-LIKE EFFECTS OF BUSPIRONE MEDIATED BY THE 5-HT1A POSTSYNAPTIC RECEPTORS IN THE LEARNED HELPLESSNESS PARADIGM

被引:44
|
作者
MARTIN, P [1 ]
TISSIER, MH [1 ]
ADRIEN, J [1 ]
PUECH, AJ [1 ]
机构
[1] UNIV PARIS 06,INSERM,U288,F-75634 PARIS 13,FRANCE
关键词
D O I
10.1016/0024-3205(91)90605-B
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The 5-HT1A receptor agonists buspirone and 8-OH-DPAT have strong effects on serotoninergic systems. Mediated by both pre- and post-synaptic 5-HT1A receptors, these pharmacological effects might predict both antidepressant and antianxiety activities. In animal models sensitive to antidepressant drugs, the 5-HT1A agonists administered i.p. have been shown to mimic the behavioral effects of tricyclics. In the present study, the learned helplessness paradigm was used to assess the possible role of pre- or post-synaptic 5-HT1A receptors in this effect. The ability of buspirone compared with 8-OH-DPAT to reduce helpless behavior was investigated after local microinjections (0.1 or 1.0-mu-g in 0.5-mu-l) into the raphe nuclei or into the septum. The results indicate that microinjections of buspirone or 8-OH-DPAT into the raphe nuclei did not reverse helpless behavior; in contrast, microinjections of both 5-HT1A agonists into the septum reverse helpless behavior. These results suggest that antidepressant-like properties of buspirone and 8-OH-DPAT may be mediated, in this test, by the post-synaptic 5-HT1A receptors through functional enhancement of the 5-HT transmission.
引用
收藏
页码:2505 / 2511
页数:7
相关论文
共 50 条
  • [41] Antidepressant-like effects of a novel curcumin derivative J147: Involvement of 5-HT1A receptor
    Lian, Lejing
    Xu, Ying
    Zhang, Jianbo
    Yu, Yingcong
    Zhu, Naping
    Guan, Xiaofei
    Huang, Hui
    Chen, Ruijie
    Chen, Jie
    Shi, Guilan
    Pan, Jianchun
    NEUROPHARMACOLOGY, 2018, 135 : 506 - 513
  • [42] 1-(2-PYRIMIDINYL)-PIPERAZINE MAY ALTER THE EFFECTS OF THE 5-HT1A AGONISTS IN THE LEARNED HELPLESSNESS PARADIGM IN RATS
    MARTIN, P
    PSYCHOPHARMACOLOGY, 1991, 104 (02) : 275 - 278
  • [43] Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test
    Miyata, S
    Hirano, S
    Kamei, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (03) : 461 - 469
  • [44] Diabetes Attenuates the Antidepressant-Like Effect Mediated by the Activation of 5-HT1A Receptor in the Mouse Tail Suspension Test
    Shigeo Miyata
    Shoko Hirano
    Junzo Kamei
    Neuropsychopharmacology, 2004, 29 : 461 - 469
  • [45] NLX-101, a highly selective 5-HT1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT1A receptors
    Depoortere, R.
    Auclair, A. L.
    Newman-Tancredi, A.
    BEHAVIOURAL BRAIN RESEARCH, 2021, 401
  • [46] Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test
    Estrada-Camarena, E
    Fernández-Guasti, A
    López-Rubalcava, C
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (02) : 247 - 255
  • [47] Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
    Heisler, LK
    Chu, HM
    Brennan, TJ
    Danao, JA
    Bajwa, P
    Parsons, LH
    Tecott, LH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 15049 - 15054
  • [48] Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice
    Cunha, Mauricio P.
    Pazini, Francis L.
    Oliveira, Agatha
    Machado, Daniele G.
    Rodrigues, Ana Lucia S.
    BRAIN RESEARCH BULLETIN, 2013, 95 : 61 - 69
  • [49] Antidepressant-like behaviour of mice overexpressing the 5-HT1A receptor in the dentate gyrus and cortex
    Bert, B
    Rex, A
    Wistel-Wozniak, A
    Fink, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 40 - 40
  • [50] CENTRAL PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS IN RATS TREATED CHRONICALLY WITH A NOVEL ANTIDEPRESSANT, CERICLAMINE
    JOLAS, T
    HAJDAHMANE, S
    KIDD, EJ
    LANGLOIS, X
    LANFUMEY, L
    FATTACCINI, CM
    VANTALON, V
    LAPORTE, AM
    ADRIEN, J
    GOZLAN, H
    HAMON, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (03): : 1432 - 1443